To better understand the effect of the C2D peptide on the CD45 signaling pathway, we analyzed the percent change in phosphorylation for each of the 4 relevant proteins, for every PBMC sample from the ten COVID-19 patients, +C24D vs. –C24D (Figure 2A). This evidence concerns the gene PTPRC and COVID-19.